Flubromazepam, also known as Flam, is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug.
It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.
Flubromazepam, clonazolam, and flubromazolam are Schedule I controlled substances under Virginia State Law.
« Back to Glossary Index